Heparin and heparan sulfate proteoglycans promote HIV-1 p17 matrix protein oligomerization: computational, biochemical and biological implications
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Heparin and heparan sulfate proteoglycans promote HIV-1 p17 matrix protein oligomerization: computational, biochemical and biological implications
Authors
Keywords
-
Journal
Scientific Reports
Volume 9, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-10-31
DOI
10.1038/s41598-019-52201-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Molecular dynamics-based model of VEGF-A and its heparin interactions
- (2018) Urszula Uciechowska-Kaczmarzyk et al. JOURNAL OF MOLECULAR GRAPHICS & MODELLING
- Structural Basis of Native CXCL7 Monomer Binding to CXCR2 Receptor N-Domain and Glycosaminoglycan Heparin
- (2017) Aaron Brown et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The ClusPro web server for protein–protein docking
- (2017) Dima Kozakov et al. Nature Protocols
- A single amino acid substitution confers B-cell clonogenic activity to the HIV-1 matrix protein p17
- (2017) Cinzia Giagulli et al. Scientific Reports
- HIV-1 matrix protein p17 misfolding forms toxic amyloidogenic assemblies that induce neurocognitive disorders
- (2017) Yasmin Zeinolabediny et al. Scientific Reports
- Computational drill down on FGF1-heparin interactions through methodological evaluation
- (2016) Sándor Babik et al. GLYCOCONJUGATE JOURNAL
- Angiogenic growth factors interactome and drug discovery: The contribution of surface plasmon resonance
- (2015) Marco Rusnati et al. CYTOKINE & GROWTH FACTOR REVIEWS
- A natural HIV p17 protein variant up-regulates the LMP-1 EBV oncoprotein and promotes the growth of EBV-infected B-lymphocytes: Implications for EBV-driven lymphomagenesis in the HIV setting
- (2015) Debora Martorelli et al. INTERNATIONAL JOURNAL OF CANCER
- Heparin/Heparan Sulfate Proteoglycans Glycomic Interactome in Angiogenesis: Biological Implications and Therapeutical Use
- (2015) Paola Chiodelli et al. MOLECULES
- Flexible and rigid structures in HIV-1 p17 matrix protein monitored by relaxation and amide proton exchange with NMR
- (2014) Yuka Ohori et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Docking Server for the Identification of Heparin Binding Sites on Proteins
- (2014) Scott E. Mottarella et al. Journal of Chemical Information and Modeling
- Dimerization Capacities of FGF2 Purified with or without Heparin-Affinity Chromatography
- (2014) Natalia Platonova et al. PLoS One
- Bridging the past and the future of virology: Surface plasmon resonance as a powerful tool to investigate virus/host interactions
- (2013) Marco Rusnati et al. CRITICAL REVIEWS IN MICROBIOLOGY
- Pathophysiology of heparan sulphate: many diseases, few drugs
- (2013) U. Lindahl et al. JOURNAL OF INTERNAL MEDICINE
- Molecular Interaction Studies of HIV-1 Matrix Protein p17 and Heparin
- (2012) Antonella Bugatti et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Opposite Effects of HIV-1 p17 Variants on PTEN Activation and Cell Growth in B Cells
- (2011) Cinzia Giagulli et al. PLoS One
- HIV-1 matrix protein p17: A candidate antigen for therapeutic vaccines against AIDS
- (2010) Simona Fiorentini et al. PHARMACOLOGY & THERAPEUTICS
- HIV-1 Tat and heparan sulfate proteoglycan interaction: a novel mechanism of lymphocyte adhesion and migration across the endothelium
- (2009) C. Urbinati et al. BLOOD
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility
- (2009) Garrett M. Morris et al. JOURNAL OF COMPUTATIONAL CHEMISTRY
- Analysis of Human Immunodeficiency Virus Type 1 Matrix Binding to Membranes and Nucleic Acids
- (2009) A. Alfadhli et al. JOURNAL OF VIROLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started